
Want to live to 100? Skip these foods in your 30s and enjoy them later. Longevity doctor shares surprising diet secret
If you're counting on steak to fuel you through the years, it might be time to rethink your plate. According to Dr. Joseph Antoun, longevity physician and CEO of the health-focused company L-Nutra, your love for animal protein could be accelerating your biological clock — especially if you're between 30 and 65.
In a recent interview with the New York Post , Dr. Antoun detailed how different kinds of protein affect aging, and why your diet should shift as you grow older. 'Animal-based diets stimulate IGF-1 and therefore help a consumer look good and muscular in the short term… but the body is in 'accelerated bio-age mode,' which leads to a shorter lifespan,' he explained.
IGF-1 (Insulin-like Growth Factor 1), a hormone key to cell growth and metabolism, can be a double-edged sword. While it supports muscle development, elevated levels—particularly triggered by animal proteins rich in arginine and leucine—can also speed up aging and disease formation in midlife. Dr. Antoun recommends tailoring your protein intake based on age. Before 30, meat can be part of a healthy, mixed diet as the body is still developing muscle and bone mass. After 65, it becomes essential again due to declining absorption and rapid muscle loss. But between those two milestones — from age 30 to 65 — the stakes change. 'This mid-life period is the age of disease formation and is when the speed and quality of aging mostly determines our lifespan,' Antoun warned.
That's why he champions the Longevity Diet , a mostly plant-based approach that prioritizes legumes, beans, nuts, and seeds over animal products. Diets like the Mediterranean, pescatarian, and flexitarian models also score high for promoting longer, healthier lives — thanks to their balance of plant-rich nutrition and heart-friendly fats. Antoun also pointed to a surprising observation: bodybuilders often look youthful in their prime but age dramatically later. 'They look great in the short term but end up looking far older than their real age in their 50s and 60s,' he said, noting that constant stimulation of IGF-1 can fast-track aging, even if it builds impressive muscle along the way. He warns that commercial food industries tend to glamorize muscular physiques as the ultimate health goal — when in fact, they may reflect an accelerated internal aging process. Dr. Antoun isn't suggesting you abandon all animal protein, especially not after 65. But he does urge caution — and selection. 'Red meat is high in saturated fats, while fish contains healthier, unsaturated fats,' he noted. Even among meats, different amino acid profiles can affect IGF-1 stimulation differently.
The bottom line? Eat plant-based when it counts the most — in your middle years — so that by the time you're in retirement, you can enjoy the occasional burger without guilt or risk.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Standard
3 hours ago
- Business Standard
Chilean Prunes Support Muscle Mass
HT Syndication New Delhi [India], August 4: Chilean prunes, known for their digestive health benefits, are also a rich source of nutrients that support muscle growth, fat loss, and enhance energy levels, all while contributing to better cognitive health. Recent research conducted at Oklahoma State University has revealed that regular consumption of prunes can significantly increase levels of IGF-1, a key protein that regulates growth hormone and supports the development of muscle and bone tissue. In the study, participants experienced a 17% increase in IGF-1, underscoring prunes potential in naturally promoting lean muscle growth. Kavita Devgan, renowned dietitian, holistic health consultant, and acclaimed author said, "Just 5-6 prunes before a workout can provide the natural energy, thanks to their blend of natural sugars, fructose and glucose and high fibre content. They also promote better blood flow and satiety, making them a perfect pre-workout snack". Mr. Sumit Saran, India Representative of Chilean prunes remarked, "Chile is known as one of the world's largest growers and suppliers of prunes. Chilean prunes are recognized globally for their high quality. Just visit your dry fruit retailer or head to the grocery store and ask for Chilean prunes." Whether blended into smoothies, enjoyed on their own, or incorporated into both sweet and savoury dishes, Chilean prunes are a versatile, tasty way to fuel fitness goals naturally. For further information, please contact:


Time of India
5 hours ago
- Time of India
Peptides: performance-boosting, anti-ageing drugs or dangerous snake oil?
Lancaster: For a growing number of middle-aged men, ageing no longer means surrendering to sagging skin, sore joints or slowing metabolism. Instead, it's becoming a science experiment. The new frontier? Injectable peptides - experimental compounds that promise rapid recovery, fat loss and muscle gains with the ease of a twice-daily to weekly jab. Once confined to elite labs and obscure bodybuilding forums, these amino acid chains are now flooding wellness spaces, social media feeds and online marketplaces. Although they are marketed as "next-generation biohacks" and "research chemicals", many peptides are not approved for human use and lack basic clinical testing. Still, their popularity is growing - fuelled by testimonials, influencer hype and the seductive promise of turning back time. But beneath the surface of glossy marketing and fitness fantasies lies a far more sobering truth: many of these substances operate in a medical grey zone, with unknown long-term risks, questionable manufacturing standards, and in some cases, life-threatening side-effects. Peptides aren't entirely new to medicine. The first peptide drug - insulin - was isolated in 1921 and became commercially available in 1923. Today over 100 peptide medications are approved, including semaglutide - better known as Ozempic and Wegovy . But the compounds now circulating in fitness communities represent a very different category. They're experimental substances that have shown promise in animal studies but have never undergone proper human trials. The ' Wolverine stack' One such compound, first discovered in human gastric juice, that is attracting lots of attention is BPC-157. Early animal studies suggest it may help repair damaged tissue throughout the body. Researchers tested it on mice, rats, rabbits and dogs without finding serious side-effects. The compound appears to support healing of the tendons, teeth and digestive organs, including the stomach, intestines, liver and pancreas. Scientists don't yet fully understand how BPC-157 works, but animal studies suggest it triggers several biological processes essential for healing. The compound appears to help cells move to damaged areas and encourages the growth of new blood vessels, bringing nutrients and oxygen to tissues in need of repair. Another compound gaining attention is TB500. It is a synthetic version of thymosin beta-4, a naturally occurring protein fragment that plays an important role in repairing and regenerating damaged cells and tissues. It also helps protect cells from further harm by reducing inflammation and defending against microbes. The combination of BPC-157 and TB500 has earned the nickname "the Wolverine stack", named after the Marvel superhero famous for his rapid healing. Then there's IGF-1 LR3, a modified version of a natural protein (IGF-1) linked to muscle growth. This synthetic compound was shown to increase muscle mass by 2.5 times in animal studies, though it has never been studied in humans. The limited human research that does exist for these compounds offers inconclusive results. For example, a study showed that over 90% of patients experienced reduced knee pain after BPC-157 injections. However, the study had no control group and several methodological issues, so the results should be viewed with caution. Hidden dangers Even though the early results seem exciting, these experimental compounds can be dangerous. Making them involves special chemicals called coupling agents, which can trigger serious allergic reactions, including anaphylaxis - a life-threatening condition. The health consequences extend well beyond allergic reactions. Long-term injection of performance-enhancing substances can lead to heart failure that can occur rapidly with little warning, as documented in recent medical case studies of young bodybuilders. Injection-related injuries pose another significant threat. "Compartment syndrome" can develop at injection sites in leg muscles, causing numbness, blood clots and muscle spasms that result in permanent loss of function. In severe cases, skin and underlying tissue can suffer necrosis (tissue death), requiring antibiotics or surgery to treat. More alarming still are reports of users contracting HIV, hepatitis B and C, and serious eye infections from contaminated injections. These compounds don't just target muscles - they affect the entire body in ways scientists are only beginning to understand. Some interfere with natural insulin production, while others activate biological pathways that healthy cells use for growth and repair. The concern is that these same pathways are exploited by cancer cells. The VEGF pathway, which promotes blood vessel growth, is active in about half of all human cancers, including melanoma and ovarian cancer. Laboratory studies suggest that thymosin beta-4 may play a role in helping colorectal and pancreatic cancers spread. While there's no direct evidence linking compounds like BPC-157 or TB500 to cancer, researchers emphasise that the long-term effects remain unknown because these substances have never undergone proper human trials. The World Anti-Doping Agency has banned these compounds, noting they lack approval from any health regulatory authority and are intended only as research tools. A growing problem Yet their use appears to be spreading rapidly. A 2014 study found that 8.2% of gym members used performance-enhancing drugs. By 2024, a comprehensive review suggested the figure could be as high as 29%. Perhaps most concerning: only 38% of users recognised the health risks involved. These experimental compounds represent a dangerous gamble with long-term health. Unlike approved drugs, they haven't undergone the rigorous testing required to understand their safety profile in humans. While they may promise enhanced performance and healing, they deliver it at a cost that users may not fully understand until it's too late. The appeal is understandable - who wouldn't want faster healing and better muscle tone? But the reality is these substances remain experimental for good reason. Until proper human trials are conducted, users are essentially volunteering as test subjects in an uncontrolled experiment with their own bodies. (The Conversation)


Time of India
7 hours ago
- Time of India
Elon Musk's Neuralink brain chip: What is it, how it helps paralysed patients and aims to merge humans with AI
Elon Musk 's Neuralink is revolutionising the way humans interact with technology by merging the power of thought with advanced computing. Its flagship innovation, a coin-sized brain implant called 'the Link,' enables individuals to control computers, smartphones, and even games just by thinking. The implant has already transformed lives, helping paralysed patients regain digital independence and communication ability. Early recipients like Noland Arbaugh, Audrey Crews, Alex, and RJ showcase how neural signals can bypass damaged pathways to restore essential functions. Beyond assisting people with disabilities, Neuralink envisions a future where humans could communicate brain-to-brain, boost memory, and even merge with artificial intelligence. However, this pioneering technology also faces significant challenges, including complex surgeries, device reliability, and ethical concerns over neural privacy and long-term brain safety. Check how Neuralink works , the individuals already benefiting from it, and how it could change the future of humanity. What is Neuralink? Inside Elon Musk's brain chip technology The Neuralink Link is a brain-computer interface (BCI) designed to record and interpret neural signals. It is implanted directly into the skull, with ultra-thin electrode threads (thinner than human hair) extending into the brain's motor cortex. These electrodes detect and interpret neural impulses associated with movement and thought processes. Once processed, the data is transmitted wirelessly to external devices like computers, tablets, and prosthetics, effectively allowing users to control technology with their minds. The implant charges wirelessly, ensuring convenience and continuous operation. How Neuralink works Surgical implantation A specialized surgical robot performs the implant procedure to ensure precision. The robot delicately inserts up to 1,024 flexible electrodes into specific brain regions without damaging nearby blood vessels or tissue. Signal detection The electrodes pick up tiny electrical impulses generated when the user thinks about performing specific actions, such as moving a cursor, selecting text, or clicking on applications. Data processing and transmission The neural signals are amplified, digitized, and processed by the implant's internal electronics. These processed signals are transmitted wirelessly to a receiver (a tablet or computer), converting thoughts into actionable commands. Adaptive learning system Neuralink's software uses machine learning to adapt to each user's unique neural patterns. Over time, accuracy improves, reducing errors and allowing faster digital control. Neuralink human trials reveal stunning breakthroughs for paralysed patients Source: New York Post Noland, paralysed from the shoulders down since a 2016 diving accident, became the first human Neuralink recipient in early 2024. The implant allowed him to play online chess, browse the internet, and use his laptop entirely via thought. Although some electrode threads retracted initially, software upgrades restored functionality, demonstrating Neuralink's ability to adapt to real-world challenges. Alex – Creativity unlocked The second recipient, known as Alex (pseudonym), used the implant for advanced digital tasks, including 3D modeling, digital art, and gaming. This success showed the device's potential beyond basic computer use, extending into professional and creative industries. Audrey Crews – The first female participant Paralyzed for over two decades, Audrey Crews became the first publicly identified female Neuralink recipient in mid-2025. She regained the ability to digitally sign her name and play interactive games for the first time in years. Her experience proved Neuralink's adaptability for different patient profiles. RJ – A Veteran's Independence restored RJ, a US military veteran, used Neuralink to control his smartphone and computer, enabling easier communication and daily digital tasks. His case highlighted Neuralink's potential in helping injured service members regain independence. Other participants (P6–P9+) By late 2025, at least nine people had received the implant as part of the PRIME clinical trial in the US and U.K. Though many remain anonymous, early reports confirmed that participants successfully executed binary commands and navigation tasks using only their thoughts. Neuralink future goals expand beyond medical applications While Neuralink's initial focus is medical restoring communication and independence for people with paralysis it has long-term ambitions that include: Memory enhancement: Storing and recalling digital memories directly from the brain. Brain-to-brain communication: Enabling direct mental communication between humans. Integration with AI: Allowing humans to interface with artificial intelligence for faster learning and cognitive enhancement. ` Neuralink's ethical and safety challenges The technology raises important questions: Privacy: Who controls neural data? Long-term health: What are the risks of chronic electrode implantation? Social impact: Could BCIs create inequality between enhanced and non-enhanced humans? Neuralink's research emphasises incremental progress, regulatory compliance, and patient safety, understanding that merging the human brain with machines requires caution as well as innovation. Also Read | Who is Arvinder Singh Bahal? The 80-year-old adventurer flying to space on Jeff Bezos' Blue Origin mission